Summit Therapeutics, Inc. (SMMT)
17.02
-1.60
(-8.62%)
USD |
NASDAQ |
Dec 09, 16:00
17.13
+0.11
(+0.65%)
After-Hours: 05:23
Summit Therapeutics Total Liabilities (Quarterly): 69.47M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Merck & Co., Inc. | 77.64B |
| CVS Health Corp. | 182.22B |
| UnitedHealth Group, Inc. | 209.46B |
| Iovance Biotherapeutics, Inc. | 202.66M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 261.73M |
| Shareholders Equity (Quarterly) | 192.26M |
| Debt to Equity Ratio | 0.0282 |
| Current Ratio | 3.796 |
| Net Debt Paydown Yield | 0.13% |